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Summary: We describe an ELISA technique for human transferrin. The test has a lowest detection limit of
2 §/1 and a wide ränge. It is specific for human transferrin and its reproducibility proved acceptable in both
intra-run and between-day examinations. Results obtained by radial immunodiffusion and by ELISA were
strongly correlated (n = 51; y = 0.92x + 16.1; r = 0.90). The cost in Israel for disposables and chemicals for
triplicate examination is $0.55 per sample. This is 7 —8 times less than the cost of a determination, using
commercial immunodiffusion plates.
This assay is of particular value where the sample size is limited, e. g. samples of l — 4 are sufficient for
the determination of transferrin in tears. The transferrin concentrations in arterial and venous cord blood
were shown to be essentially identical and similar to that in adult blood.
Introduction
It is well documented that a great number of patho-
logical conditions may be assoeiated with abnormal
transferrin metabölism (l —8). The need for sensitive
methods for quantitation of transferrin in a great
variety of samples (serum, semen (9), exocrine secre-
tions (10), cell cültüres (8)) is therefore increasing.
The assays mpst commpnly used at present (radial
immunodiffusion, nephelometry and the iron capacity
method) have low sensitivity, and the results from
these different methods sometimes show a poor cor-
relation (11 — 12). We present an ELISA technique
that is simple to perform and cost-effective, and which
has ä high sensitivity and specificity. The technique
may be particularly useful for samples of restricted
size (tears, blood from neonates) and/or of low con-
centration. An electronic literature search (Medline)
has not retrieved any reference to the adaptation of
ELISA techniques for traasferrin (up to March 1987).
Materials and Methods
Materials
Initially, two different Standards were used: purifled human
transferrin (T3400, Sigma Ltd., St. Louis, USA) and human
serum calibrated for transferrin level (Behringwerke AG, Mar-
burg). Lateir, since the ELISA technique showed good agree-
ment between the transferrin Contents indicated by the manu-
facturers, only the Behringwerke Standard was used routinely.
Affinity purified rabbit anti-human transferrin (Pharmacia
Ltd., Uppsala, Sweden) was used in the ELISA both äs catching
and äs detecting antibody. The portion used for detection was
biotinylated with biotin N-hydroxy succinimide (13) in our
laboratory. The biotinylated immunoglobulin is stable for at
least 6 months. It is stored at —20°C in 5 portions and
thawed only for use.
Alkaline phosphatase2)-conjugated avidin, phosphatase sub-
strate (4-nitrophenylphosphate disodium salt), various animal
transferrins and agarose were products of Sigma Ltd.
Radial immunodiffusion
Anti-transferrin at 3 /cm2 was added to agarose (10 g/l) in
phosphate-bufTered saline (pH 7.2). Serum samples at a l: 10
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dilution were applied in a volume of 4 μΐ. After 24 hours at
room temperature, the diffusion diameters were recorded for
Standard and unknown samples.
ELISA procedure
Wells of microtiter plates (M129B, Dynatech) were coated with
anti-transferrin in tris-buffer (Tris (hydroxymethyl) amino-
methane 1.21 g/l; NaCl 5.84 g/l; pH 8.5) and stored at 4 °C for
up to 14 days. The actual analysis was performed on two
subsequent days:
First day
1. Post-coating with 30 g/l bovine serum albumin in tris-buffer.
2. Standard samples in a two-fold dilution gradient (2—4 wells
for each dilution) and appropriately diluted clinical samples
(3 wells for each) were incubated for 2 hours at room
temperature. The dilutions were performed in phosphate-
buffered saline (NaCl 29.2 g/l; KC1 0.2 g/l; KH2PO4 0.2 g/l;
Na2HPO4 1.2 g/l; pH 7.2) containing 10 g/l bovine serum
albumin.
3. Rinsing and application of the biotinylated anti-transferrin
diluted l: l O4 in phosphate-buffered saline containing 10 g/l
bovine serum albumin. Incubation for 2 hours at room
temperature (20 °C) and overaight at 4 °C.
Second day
1. Rinsing and application of phosphatase-conjugated avidin
(2300 U/l of alkaline phosphatase; 2 mol of phosphatase per
mol of avidin). Incubation for two hours at room tempera-
ture.
2. Rinsing and application of phosphatase Substrate (4-nitro-
phenylphosphate disodium salt l g/l in glycine buffer: glycine
7.5 g/l; ZnCl2 130 μ^Ι; MgCl2 200 μ§/1; pH 10.4), incubation
at room temperature (20 °C), 120 min.
3. Absorbance at 405 nm was recorded on a Flow Titertek
Multiskan.
Results of unknown samples can be obtained either from a
best-fit curve of absorption against log-concentration or, s in
our routine, from a computerized log-logit SAS-program (Sta-
tistical Analysis System). The computer-generated least-squares
curve was used to determine the reliable r nge of concentrations
according to two criteria:
1. Maximal variations of less than 25% from the average
absorbance obtained with multiple samples of a certain
dilution;
2. essential linearity of the log-logit curve.
Results
Detection limit and concentration r nge
As seen in figure l, the reliable r nge of the assay is
at least 2-128 μg/l. This is wider than the r nge of
variations of transferrin levels observed in most kinds
of clinical specimens. Therefore, one dilution of the
samples can be chosen so that virtually all of them
will fall within the concentration r nge of the assay.
In practice, we routinely diluted serum l: l O5; am-
niotic fluid 2:104; tears from inflamed eyes l: 103 and
tearc from non-inflamed eyes 2: l O2. Figure 2, based
on sera from seven patients, shows a linear correlation
between the degree of dilution and the measured
concentration.
1.8
1.6
1.4
1.2
l 1.0
Z
< 0.8
0.6
0,4
0.2
0.0;
i
2.0
1.0
0.0
l -1·0
<
-^
'§* -2.0
-3.0
-4.0
-5.0
1 8 16 32 64
Trqnsferrih ( μς/Π
128 256
8 16 32 64
Transferrin [μς/U
128 256
Fig. 1. Standard curve for ELISA of human transferrin.
Abscissa: transferrin concentrations of a series of double
dilutions of a commercial calibrated serum. Each dilu-
tion was assayed in quadruplicate.
Ordinate: A4o5nm; mean and SD are indicated.
l a. Concentration versus 4o5nm.
Ib. Concentration versus the logit
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Fig. 2. Transferrin determination by ELISA with 7 sera diluted
* to different degrees.
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Specificity
In the assay the following proteins (all from Sigma
Ltd.) gave spectrophotometric readings of A^snm
< 0.09: Ferritin (final concentration l mg/1); lacto-
ferrin (50 mg/1); bovine transferrin (50 mg/1); equine
transferrin (50 mg/1); and rabbit transferrin (50 mg/1).
The specificity of the anti-transferrin was confirmed
in double immunodiffusion assays with human, bo-
vine and equine transferrin (details not shown).
Tab. 1. Intra-assay variance of transferrin determination by
ELISA.
A serum sample was diluted to give 4 different final
concentrations. Each of the diluted samples was assayed
in 20 welis of a microtiter plate.
Sample
No.
1
2
3
4
Transferrin
(Μβ/1)
14.1
27.6
55.3
127.3
CV
(%)
7.0
7.5
16.1
13.3
Transferrin concentrations assessed by
ELISA and radial immunodiffusion
Figure 3 compares the transferrin concentrations of
51 serum specimens assessed by radial immunodiffu-
sion (RID) and by ELISA. The least-squares line was
y = 0.92x +16.1 and the correlation coeffitient
r = 0.90. The sera were diluted 1:10 for RID and
l :105 for ELISA.
Tab. 2. Inter-assay variance of transferrin determination by
ELISA.
The samples were examined on 10 different days, each
time in triplicate.
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Fig. 3. Comparison between transferrin concentrations (g/l) of
51 seruni samples assessed by radial immunodiffusion
(RID) and ELISA.
The least-squares line was y = 0.92x + 16.1.
The correlation coeflficient r = 0.90.
Reproducibility
table l shpws ain intra-run variance of about 7% for
sample dilutions assayed at final concentrations of 14
and 28 μg/l and of 13 — 16% for final concentrations
of 55 and 127 μg/L Analysis of samples in triplicate,
in 10 different runs showed a day-to-day variance of
<10% for low and moderately high concentrations,
and 15% for high concentrations (tab. 2).
Sample
No.
1
2
3
4
Transferrin
fag/l)
Mean of all
determinations
15.8
28.6
55.4
128.0
Day to day
CV (%)
of the mean
6.2
9.8
9.1
15.2
Some practical applications
A. Dissanayake & deSilva (14) have found that the
serum transferrin concentrations of neonates were
about 35% of normal adult levels. This stimulated us
to try to calculate the possible transplacental transfer
of maternal transferrin by using the difference be-
tween the concentrations in venous and arterial cord
blood. However, for 10 neonates examined, the trans-
ferrin concentrations of venous and arterial cord
blood were comparable and not distinct from adult
levels (tab. 3). We have no explanation for the dis-
crepancy with the results of the above-mentioned
study (14). The transferrin concentration of amniotic
fluid was 189.4 ± 66.1 mg/1.
B. Some plasma proteins can be used s markers for
the leakage of macromolecules from the circulation
to mucous membranes, e. g. s a measure of the in-
tensity of inflammation or in immunological studies
(15). A marker protein must be one that is not syn-
thesized by cells of the mucous membrane. Both al-
bumin (16) and transferrin (10) have been used s
marker proteins for tears. Both groups of investiga-
tors used RID to quantitate their marker proteins. It
has been claimed that transferrin is absent from tears
of healthy eyes (17-19). However, by the ELISA
technique, all the tear samples examined were shown
to contain transferrin, with concentration ranges of
0.2-14 mg/1 (mean = 4.3 mg/1) in healthy controls
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Tab. 3. Transferrin concentrations of arterial and venous cord blood and amniotic flüid from 10 full-term neonates.
Arterial cord blood
Venous cord blood
Amniotic fluid
n
10
10
10
Transferrin
± s
(mg/1)
2263 ± 496
2174 ± 708
189.4+ 66.1
r (P)
0.94 (< 0.001)
-0.14 (>0.1)
ta(p)
0.95 (>0.1)
• t
paired t-test
Tab. 4. Concentration of transferrin in tear fluid and serum of vernal conjunctivitis patients and healthy controls.
Tear fluid Serum Ratio
xt ± s (mg/1) xs ± s (mg/1)
Controls
Vernal conjunctivitis
15
22
4.3 -h 4.7
108 ±76.1
8
11
2133 ± 527
2358 ± 1073
0.002
0.046
The differences between transferrin concentrations for patients and healthy controls were tested for significance by unpaired t-
test.
For tears: t = 5.28; df = 35; p < 0.0005
For serum: t = 0.44; df = 17; p: 0.30-0.35
and 10—270 mg/1 (mean = 108 mg/1) in patients with
inflamed eyes (tab. 4). Table 5 compares the transu-
dation coefficients of tears calculated from serum
albumin (RID) and transferrin (ELISA) concentra-
tions of tears and serum. Considering the differences
between the techniqües used, the agreement between
the results is satisfactory.
Discussion
The role of transferrin in a wide ränge of pathological
conditions must be determined with the aid of new
sensitive and wide-range assays for this protein. By
using anti-transferrin labeled with biotin, we were able
to develop an ELISA technique for transferrin, using
a single monospecific commercial rabbit antibody.
The test is of particular value for the analysis of
clinical samples that are available only in very small
amounts (e. g. tears) and are often destined for a large
battery of tests. In terms of sensitivity and the width
of the concentration ränge, the assay is comparable
with, or even better than, the recently described ra-
dioimmunoassay (20) and luminescence immunoassay
(21) for transferrin. Precision was a little less than for
the chemiluminescent method (21) but comparable
with the results of the RIA (20).
This ELISA test is very cost effective, at leäst in Israel.
The direct costs for disposables and immunochemicals
Tab. 5. Transudation coefficients (tear/blood levels) assessed
from serum albumin and transferrin separately for tears
of 9 vernal conjunctivitis patients.
Patient
No.
1
2
3
4
5
6
7
8
9
Right Eye
Albumin
0.01
0.04
0.04
0.09
0.06
0.05
0.14
0.06
0.05
Transfemn
0.01
0.04
0.03
0.07
0.04
0.05
0.16
0.05
0.05
Left Eye
Albumin
0.03
0.03
0.03
0.08
0.09
0.06
0.08
0.09
0.02
Transfemn
0.02
0.03
0.02
0.05
0.08
0.07
0.12
0.09
0.01
For albumin transudation coefficient (n = 18): ± s = 0.06
± 0.03
For transferrin, ± s = 0.06 ± 0.04
Correlation coefficient r = 0.92, p < 0.001
are $0.55 per sample tested in triplicate. The working
time for a load of 20 samples (in triplicate) is 150 min
on the first day and 90 min on the second day of the
assay, or 12 min per test. A commercial agar plate
for RID for transferrin costs about $50 for 12 sam-
ples, i. e. more than $4 per test.
The ELISA technique caii easily be performed in one
day. A two-day programme is, however, more cön-
venient for laboratory technicians, who also perform
a wide ränge of other düties.
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